Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Rotolo

Vascular & Interventional Radiology Miami, FL Medical Doctor

NPI 1386964047 CMS profile 1376453

8900 N Kendall Dr, McVi, Miami, FL 33176

Open in the dashboard

General payments

$171,475

322 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul Rotolo of Miami, FL is reported in the CMS Open Payments database as having received $171,475 across 322 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $38,735 31
2024 General $39,304 66
2023 General $50,563 84
2022 General $36,393 56
2021 General $1,986 25
2020 General $1,094 14
2019 General $3,400 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Rotolo
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Paul Rotolo were reported at $38,735. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Paul Rotolo Vascular & Interventional Radiology median Middle half National median
2019 $3,400 $422 $125–$1,555 $163
2020 $1,094 $200 $68–$652 $114
2021 $1,986 $280 $99–$866 $132
2022 $36,393 $433 $137–$1,497 $149
2023 $50,563 $506 $152–$2,019 $160
2024 $39,304 $556 $175–$1,930 $164
2025 $38,735 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $163,850 213 payments
  2. Boston Scientific Corporation $3,437 44 payments
  3. Medtronic, Inc. $954 17 payments
  4. Inari Medical, Inc. $787 7 payments
  5. Medtronic Vascular, Inc. $332 6 payments
  6. Philips Electronics North America Corporation $329 4 payments
  7. Balt USA, LLC $258 2 payments
  8. Janssen Pharmaceuticals, Inc $232 3 payments
  9. AngioDynamics, Inc. $193 6 payments
  10. Stryker Corporation $167 1 payment
  11. Other $937 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $107,864 39 payments
  2. Travel and Lodging $36,874 74 payments
  3. Food and Beverage $21,212 199 payments
  4. Consulting Fee $5,525 10 payments
Products named General payments · program years 2019–2025
  1. Indigo System $145,361 175 payments
  2. RUBY Coil $15,613 16 payments
  3. Indigo $2,273 15 payments
  4. FLOWTRIEVER CATHETER, S $1,006 9 payments
  5. Penumbra System $805 8 payments
  6. CT THROMBECTOMY SYSTEM KIT $569 5 payments
  7. Ellipsys $568 8 payments
  8. Penumbra Ruby Coil $403 7 payments
  9. General - Vascular Intervention $398 4 payments
  10. Prestige Coil System $258 2 payments
  11. Other $3,941 75 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 242 billing codes

Paid by Medicare

$120,454

Medicare's payments for the services billed

Medicare patients

1,763

Average age 75

Services billed

3,176

967 women, 796 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Ischemic heart disease 41%
Chronic kidney disease 40%
Diabetes 39%
Atrial fibrillation 33%
COPD 33%
Depression 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

322 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record